doi: 10.3389/fphar.2025.1689575 Received 20 August 2025 Revised 22 October 2025 Accepted 27 October 2025 Published 21 November 2025 Volume 16 - 2025 Edited by Mamunur Rashid, University of Nebraska Medical Center, United States Reviewed by Franois Trottein, Institut Pasteur de Lille, France Yunlei Zhang, Nanjing Medical University, China Updates Copyright 2025 Ruan, Lin, Lin, Zhan, Zheng, Lin, Zhuang and Zeng
Within laboratory settings, IGF-1 LR3 is utilized to examine receptor-ligand interactions and intracellular signaling pathways associated with growth factor systems
Autonomic dysfunction can occur at any age: pediatric, adult, or geriatric
P.SchmidtD.SteinC
The acetyl group allows the supplement to pass easily through the blood-brain barrier
VP: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing review & editing